Shanghai Rendu Biotechnology Co. Ltd. A (688193) — Financial Flexibility Index
Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Financial Flexibility Index of 0.39x as of December 2025. Free cash flow of CN¥29.48 Million (operating CF CN¥22.41 Million minus capex CN¥7.07 Million) represents 0% of total liabilities (CN¥76.26 Million). Check Shanghai Rendu Biotechnology Co. Ltd. A (688193) asset resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Rendu Biotechnology Co. Ltd. A Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Shanghai Rendu Biotechnology Co. Ltd. A across 7 annual periods. See Shanghai Rendu Biotechnology Co. Ltd. A current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)
Year-by-year free cash flow to debt coverage for Shanghai Rendu Biotechnology Co. Ltd. A. For the full company profile including market capitalisation, see market cap of Shanghai Rendu Biotechnology Co. Ltd. A.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | CN¥29.48 Million | CN¥22.41 Million | CN¥76.26 Million | ▼ -8.7% |
| 2024 | 0.42x | CN¥34.91 Million | CN¥24.39 Million | CN¥82.48 Million | ▲ +3.6% |
| 2023 | 0.41x | CN¥37.58 Million | CN¥17.19 Million | CN¥91.97 Million | ▲ +203.8% |
| 2022 | 0.13x | CN¥17.12 Million | CN¥-4.09 Million | CN¥127.34 Million | ▼ -84.9% |
| 2021 | 0.89x | CN¥80.92 Million | CN¥54.44 Million | CN¥90.86 Million | ▼ -21.2% |
| 2020 | 1.13x | CN¥108.15 Million | CN¥92.61 Million | CN¥95.75 Million | ▼ -40.0% |
| 2019 | 1.88x | CN¥68.49 Million | CN¥13.67 Million | CN¥36.41 Million | — |